Suppr超能文献

脓毒症的临床诊断以及生物标志物与基于培养和非培养检测方法的联合应用。

Clinical diagnosis of sepsis and the combined use of biomarkers and culture- and non-culture-based assays.

作者信息

Bloos Frank

机构信息

Department of Anesthesiology and Intensive Care Medicine, University Hospital of Jena, Erlanger Allee 101, 07747, Jena, Germany,

出版信息

Methods Mol Biol. 2015;1237:247-60. doi: 10.1007/978-1-4939-1776-1_19.

Abstract

Sepsis is among the most common causes of death in hospitalized patients, and early recognition followed by immediate initiation of therapy is an important concept to improve survival in these patients. According to the definition of sepsis, diagnosis of sepsis requires the recognition of the systemic inflammatory response syndrome (SIRS) caused by infection as well as recognition of possible infection-related organ dysfunctions for diagnosis of severe sepsis or septic shock. Both SIRS and organ dysfunctions may occur frequently in hospitalized patients for various reasons. However, the fast recognition of acute infection as a cause of SIRS and newly developed organ dysfunction may be a demanding task since culture-based results of microbiological samples will be available only days after onset of symptoms. Biomarkers and PCR-based pathogen detection may help the physician in differentiating SIRS from sepsis. Procalcitonin (PCT) is the best investigated biomarker for this purpose. Furthermore, the current data support the usage of PCT for guidance of antimicrobial therapy. C-reactive protein (CRP) may be used to monitor the course of infection but has only limited discriminative capabilities. Interleukin-6 is widely used for its fast response to the infectious stimulus, but conclusive data for the application of this biomarker are missing. None of the available biomarkers can by itself reliably differentiate SIRS from sepsis but can aid and shorten the decision process. PCR-based pathogen detection can theoretically shorten the recognition of the underlying pathogen to about 8 h. However, this technique is expensive and requires additional staff in the laboratory; controlled prospective studies are missing. Although current studies suggest that PCR-based pathogen detection may be useful to shorten time to adequate antimicrobial therapy and diagnose invasive Candida infections, no general recommendations about the application of PCR for the diagnosis of sepsis can be given.

摘要

脓毒症是住院患者最常见的死亡原因之一,早期识别并立即开始治疗是提高这些患者生存率的重要理念。根据脓毒症的定义,脓毒症的诊断需要识别由感染引起的全身炎症反应综合征(SIRS)以及识别可能与感染相关的器官功能障碍,以诊断严重脓毒症或脓毒性休克。SIRS和器官功能障碍可能因各种原因在住院患者中频繁发生。然而,快速识别急性感染是SIRS和新出现的器官功能障碍的原因可能是一项艰巨的任务,因为基于培养的微生物样本结果要在症状出现数天后才会获得。生物标志物和基于PCR的病原体检测可能有助于医生区分SIRS和脓毒症。降钙素原(PCT)是为此目的研究得最好的生物标志物。此外,目前的数据支持使用PCT指导抗菌治疗。C反应蛋白(CRP)可用于监测感染过程,但鉴别能力有限。白细胞介素-6因其对感染刺激的快速反应而被广泛使用,但关于该生物标志物应用的确凿数据尚缺。现有的生物标志物都不能单独可靠地区分SIRS和脓毒症,但可以帮助并缩短决策过程。基于PCR的病原体检测理论上可以将潜在病原体的识别时间缩短至约8小时。然而,这项技术成本高昂,需要实验室增加人员;缺乏对照的前瞻性研究。尽管目前的研究表明基于PCR的病原体检测可能有助于缩短开始适当抗菌治疗的时间并诊断侵袭性念珠菌感染,但对于PCR在脓毒症诊断中的应用无法给出一般性建议。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验